Variables | French treated cohort | FDA treated cohort | ||||||
---|---|---|---|---|---|---|---|---|
R2 value | r Value | β (SE) Value | p Value | R2 value | r Value | β (SE) value | p Value | |
mPAP | 0.04 | −0.20 | −2.95 (1.66) | 0.082 | 0.04 | −0.21 | −1.67 (0.87) | 0.058 |
sPAP | 0.06 | −0.23 | −1.98 (0.98) | 0.049 | 0.06 | −0.23 | −1.18 (0.55) | 0.034 |
dPAP | 0.03 | −0.16 | −3.23 (2.09) | 0.128 | 0.09 | −0.30 | −3.75 (1.33) | 0.006 |
CO | 0.01 | 0.07 | 9.16 (10.82) | 0.401 | 0.19 | 0.44 | 29.06 (6.48) | <0.001 |
CI | 0.01 | 0.09 | 15.31 (20.10) | 0.449 | 0.20 | 0.45 | 59.84 (12.97) | <0.001 |
mRAP | 0.10 | −0.31 | −7.84 (3.12) | 0.015 | 0.08 | −0.28 | −5.60 (2.11) | 0.009 |
PVR | 0.01 | −0.09 | −0.08 (0.07) | 0.244 | 0.05 | −0.22 | −4.85 (2.78) | 0.086 |
SV | 0.04 | 0.20 | 1.34 (0.81) | 0.105 | 0.22 | 0.47 | 4.80 (1.00) | <0.001 |
Statistical significance level was set at p<0.05.
6MWD, 6-min walk distance; CI, cardiac index; CO, cardiac output; FDA, Food and Drug Administration; mPAP, mean pulmonary arterial pressure; sPAP, systolic pulmonary arterial pressure; dPAP, diastolic pulmonary arterial pressure; mRAP, mean right atrial pressure; PVR, pulmonary vascular resistance; RHC, right-heart catheterisation; SV, stroke volume.